EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland

Danielle J Leighton, Morad Ansari, Judith Newton, Elaine Cleary, Laura Stephenson, Emily Beswick, Javier Carod Artal, Richard Davenport, Callum Duncan, George H Gorrie, Ian Morrison, Robert Swingler und 5 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12450-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2024. Verfasst von Danielle J Leighton und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology & Neuroscience, University of Glasgow, Glasgow, UK. Danielle.leighton@glasgow.ac.uk. Hauptthemen laut MEDLINE: Motor Neuron Disease, Phenotype, C9orf72 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, Scottish Government Health and Social Care Directorate, MND Scotland, Motor Neurone Disease Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Using the Clinical Audit Research and Evaluation of Motor Neuron Disease (CARE-MND) database and the Scottish Regenerative Neurology Tissue Bank, we aimed to outline the genetic epidemiology and phenotypes of an incident cohort of people with MND (pwMND) to gain a realistic impression of the genetic landscape and genotype–phenotype associations.

Methods

Phenotypic markers were identified from the CARE-MND platform. Sequence analysis of 48 genes was undertaken. Variants were classified using a structured evidence-based approach. Samples were also tested for C9orf72 hexanucleotide expansions using repeat-prime PCR methodology.

Results

339 pwMND donated a DNA sample: 44 (13.0%) fulfilled criteria for having a pathogenic variant/repeat expansion, 53.5% of those with a family history of MND and 9.3% of those without. The majority (30 (8.8%)) had a pathogenic C9orf72 repeat expansion, including two with intermediate expansions. Having a C9orf72 expansion was associated with a significantly lower Edinburgh Cognitive and Behavioural ALS Screen ALS-Specific score ( p = 0.0005). The known pathogenic SOD1 variant p.(Ile114Thr), frequently observed in the Scottish population, was detected in 9 (2.7%) of total cases but in 17.9% of familial cases. Rare variants were detected in FUS and NEK1 . One individual carried both a C9orf72 expansion and SOD1 variant.

Conclusions

Our results provide an accurate summary of MND demographics and genetic epidemiology. We recommend early genetic testing of people with cognitive impairment to ensure that C9orf72 carriers are given the best opportunity for informed treatment planning. Scotland is enriched for the SOD1 p.(Ile114Thr) variant and this has significant implications with regards to future genetically-targeted treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Motor Neuron DiseasePhenotypeC9orf72 ProteinHumansScotlandMaleFemaleMiddle AgedAgedGenotypeAdultDNA Repeat ExpansionCohort StudiesAged, 80 and overSuperoxide Dismutase-1

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisC9orf72Genetic epidemiologyGenotype-phenotypeMotor neuron diseaseSOD1

Substanzen

C9orf72 ProteinC9orf72 protein, humanSuperoxide Dismutase-1SOD1 protein, human

Autor:innen und Institutionen

  • School of Psychology & Neuroscience, University of Glasgow, Glasgow, UK. Danielle.leighton@glasgow.ac.uk.
  • The Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh, Edinburgh, UK. Danielle.leighton@glasgow.ac.uk.
  • Anne Rowling Regenerative Neurology Clinic, Royal Infirmary, Edinburgh, UK. Danielle.leighton@glasgow.ac.uk.
  • Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. Danielle.leighton@glasgow.ac.uk.
  • Institute of Neurological Sciences, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. Danielle.leighton@glasgow.ac.uk.
  • South East Scotland Genetics Service, Western General Hospital, Edinburgh, UK.

Förderung

  • Chief Scientist Office, Scottish Government Health and Social Care Directorate
  • MND Scotland
  • Motor Neurone Disease Association

Zitieren

APA

Leighton, D. J., Ansari, M., Newton, J., Cleary, E., Stephenson, L., Beswick, E., Carod Artal, J., Davenport, R., Duncan, C., Gorrie, G. H., Morrison, I., Swingler, R., Deary, I. J., Porteous, M., Chandran, S., Pal, S., & Lothian Birth Cohorts Group, the CARE-MND Consortium (2024). Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland. Journal of Neurology. https://doi.org/10.1007/s00415-024-12450-w

Vancouver

Leighton DJ, Ansari M, Newton J, Cleary E, Stephenson L, Beswick E, et al. Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland. Journal of Neurology. 2024. doi:10.1007/s00415-024-12450-w

BibTeX
@article{Leighton2024,
  author = {Leighton, Danielle J and Ansari, Morad and Newton, Judith and Cleary, Elaine and Stephenson, Laura and Beswick, Emily and Carod Artal, Javier and Davenport, Richard and Duncan, Callum and Gorrie, George H and Morrison, Ian and Swingler, Robert and Deary, Ian J and Porteous, Mary and Chandran, Siddharthan and Pal, Suvankar and Lothian Birth Cohorts Group, the CARE-MND Consortium, Lothian Birth Cohorts Group, the CARE-MND Consortium},
  title = {Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12450-w}
}
Kostenlos starten →